20-32019024-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001365692.1(CCM2L):c.548C>A(p.Ala183Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000829 in 1,327,516 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001365692.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCM2L | NM_001365692.1 | c.548C>A | p.Ala183Glu | missense_variant | 5/10 | ENST00000452892.3 | NP_001352621.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCM2L | ENST00000452892.3 | c.548C>A | p.Ala183Glu | missense_variant | 5/10 | 2 | NM_001365692.1 | ENSP00000392448.2 | ||
CCM2L | ENST00000262659.12 | c.548C>A | p.Ala183Glu | missense_variant | 5/9 | 1 | ENSP00000262659.8 | |||
ENSG00000226239 | ENST00000653258.1 | n.704+9904G>T | intron_variant | |||||||
ENSG00000226239 | ENST00000662576.1 | n.815+9904G>T | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.0000593 AC: 9AN: 151756Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.0000859 AC: 101AN: 1175760Hom.: 1 Cov.: 31 AF XY: 0.0000803 AC XY: 46AN XY: 572634
GnomAD4 genome AF: 0.0000593 AC: 9AN: 151756Hom.: 0 Cov.: 33 AF XY: 0.0000270 AC XY: 2AN XY: 74120
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 02, 2023 | The c.548C>A (p.A183E) alteration is located in exon 5 (coding exon 5) of the CCM2L gene. This alteration results from a C to A substitution at nucleotide position 548, causing the alanine (A) at amino acid position 183 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at